Abstract
Bacteriochlorin a (BCA), a derivative of bacteriochlorphyll a, is an effective photosensitiser in vitro and in vivo. BCA has a major absorption peak at 760 nm where tissue penetration is optimal. This property, together with rapid tissue clearance promises minor skin photosensitivity. The tissue localising and photodynamic properties of BCA were studied using isogeneic RMA mammary tumours, transplanted into subcutaneous tissue in transparent 'sandwich' observation chambers on the back of WAG/Rij rats. The fluorescence kinetics following an i.v. administration of 20 mg kg-1 BCA was assessed in blood vessels, tumour and normal tissue. Subsequently, the development of vascular- and tissue damage after a therapeutic light dose (760 nm, 600 J cm-2) was observed. Fifteen minutes post injection (p.i.), the fluorescence of BCA in the tumour reached a plateau value of 2.5 times the fluorescence in the normal tissue. From 1 h post injection the tumour fluorescence diminished gradually; after 24 h, the tumour fluorescence signal did not exceed that of the normal tissue. Following photodynamic therapy (PDT), 24 h p.i., complete vascular stasis was observed 2 h post treatment in the tumour only, with subsequent recovery. The presence of viable tumour cells following PDT was assessed by histology and re-transplantation of treated tumour tissue from the chamber into the flank immediately or 7 days after treatment. In both cases tumour regrowth was observed. BCA-PDT (20 mg kg-1, 760 nm, 100 J cm-2) 1 h after BCA administration, an interval which gives the optimal differential between tumour and normal tissue, was sufficient to prevent tumour regrowth. However, this only occurred when re-transplantation was performed 7 days after PDT. During PDT, 1 h p.i., vascular damage in tumour and normal tissue was considerable. Complete vascular shut-down was observed in the tumour 2 h after therapy and in the surrounding tissues at 24 h. Circulation damage was associated with vascular spasm and occlusion probably due to thrombi formation. Oedema was notable, especially following PDT with 600 J cm-2 at 24 h p.i.
Full text
PDF
Images in this article
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Fingar V. H., Henderson B. W. Drug and light dose dependence of photodynamic therapy: a study of tumor and normal tissue response. Photochem Photobiol. 1987 Nov;46(5):837–841. doi: 10.1111/j.1751-1097.1987.tb04856.x. [DOI] [PubMed] [Google Scholar]
- Gomer C. J. Preclinical examination of first and second generation photosensitizers used in photodynamic therapy. Photochem Photobiol. 1991 Dec;54(6):1093–1107. doi: 10.1111/j.1751-1097.1991.tb02133.x. [DOI] [PubMed] [Google Scholar]
- Henderson B. W., Dougherty T. J. How does photodynamic therapy work? Photochem Photobiol. 1992 Jan;55(1):145–157. doi: 10.1111/j.1751-1097.1992.tb04222.x. [DOI] [PubMed] [Google Scholar]
- Henderson B. W., Sumlin A. B., Owczarczak B. L., Dougherty T. J. Bacteriochlorophyll-a as photosensitizer for photodynamic treatment of transplantable murine tumors. J Photochem Photobiol B. 1991 Sep;10(4):303–313. doi: 10.1016/1011-1344(91)80016-b. [DOI] [PubMed] [Google Scholar]
- Lam S., Palcic B., McLean D., Hung J., Korbelik M., Profio A. E. Detection of early lung cancer using low dose Photofrin II. Chest. 1990 Feb;97(2):333–337. doi: 10.1378/chest.97.2.333. [DOI] [PubMed] [Google Scholar]
- Reed M. W., Miller F. N., Wieman T. J., Tseng M. T., Pietsch C. G. The effect of photodynamic therapy on the microcirculation. J Surg Res. 1988 Nov;45(5):452–459. doi: 10.1016/0022-4804(88)90195-3. [DOI] [PubMed] [Google Scholar]
- Reinhold H. S., Blachiewicz B., Berg-Blok A. Reoxygenation of tumours in "sandwich" chambers. Eur J Cancer. 1979 Apr;15(4):481–489. doi: 10.1016/0014-2964(79)90083-5. [DOI] [PubMed] [Google Scholar]
- Richter A. M., Waterfield E., Jain A. K., Allison B., Sternberg E. D., Dolphin D., Levy J. G. Photosensitising potency of structural analogues of benzoporphyrin derivative (BPD) in a mouse tumour model. Br J Cancer. 1991 Jan;63(1):87–93. doi: 10.1038/bjc.1991.18. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Schuitmaker J. J., Vrensen G. F., van Delft J. L., de Wolff-Rouendaal D., Dubbelman T. M., de Wolf A. Morphologic effects of bacteriochlorin a and light in vivo on intraocular melanoma. Invest Ophthalmol Vis Sci. 1991 Sep;32(10):2683–2688. [PubMed] [Google Scholar]
- Schuitmaker J. J., van Best J. A., van Delft J. L., Dubbelman T. M., Oosterhuis J. A., de Wolff-Rouendaal D. Bacteriochlorin a, a new photosensitizer in photodynamic therapy. In vivo results. Invest Ophthalmol Vis Sci. 1990 Aug;31(8):1444–1450. [PubMed] [Google Scholar]
- Star W. M., Marijnissen H. P., van den Berg-Blok A. E., Versteeg J. A., Franken K. A., Reinhold H. S. Destruction of rat mammary tumor and normal tissue microcirculation by hematoporphyrin derivative photoradiation observed in vivo in sandwich observation chambers. Cancer Res. 1986 May;46(5):2532–2540. [PubMed] [Google Scholar]
- van Leengoed E., Versteeg J., van der Veen N., van den Berg-Blok A., Marijnissen H., Star W. Tissue-localizing properties of some photosensitizers studied by in vivo fluorescence imaging. J Photochem Photobiol B. 1990 Jun;6(1-2):111–119. doi: 10.1016/1011-1344(90)85080-g. [DOI] [PubMed] [Google Scholar]